Depression and coronary heart disease: A review for cardiologists

Clinical Cardiology

Volumn 20, Issue 3, 1997, Pages 196-200

  Carney, Robert M ^a   Freedland, Kenneth E ^a   Sheline, Yvette I ^a   Weiss, Edward S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

coronary heart disease; depression; emotional distress; treatment

Indexed keywords

AMFEBUTAMONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; WARFARIN;

CARDIOLOGY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DEPRESSION; HUMAN; ISCHEMIC HEART DISEASE; PROGNOSIS; REVIEW;

EID: 0030941119     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960200304     Document Type: Review

References (50)

1. Cassem H, Hackett TP: Psychiatric consultation in a coronary care unit. Ann Intern Med 1971 ;75:9-14
2. Cay EL, Vetter N, Philip AE, Dugard P: Psychological status during recovery from an acute heart attack. J Psychosoin Res 1972; 16:425-435
3. Croog SH, Levine S: Life after Heart Attack. New York: Human Sciences Press Inc., 1982
4. Camey RM, Freedland KE, Jaffe AS: Insomnia and depression prior to myocardial infarction. PsychosomMed 1990;52:603-609
5. Forrester AW, Lipsey JR, Teitelbaum ML, DePaulo JR, Andrzejewski PL, Robinson RG: Depression following myocardial infarction. IntJ Psychiatry Med 1992;22:33-46
6. Ladwig KH, Lehmacher W, Roth R, Breithhardt G, Budde T, Borggrefe M: Factors which provoke post-infarction depression: Results from the post-infarction late potential study. J Psychosom Res 1992;36:723-729
7. Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin R, Zucker HD: The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149:1785-1789
8. Camey RM, Rich MW, Tevelde AJ, Freedland KE, Saini J, Simeone C, Clark K: Major depressive disorders in coronary artery disease. Am J Cardiol 1987;60:1273-1275
9. Blazer DTG, Keller RC, McGonagle KA, Swartz MS: The prevalence and distribution of major depression in a national community sample: The national comorbidity survey. Am J Psychiatry 1994; 151:979-986
10. American Psychiatric Association: Diagnostic and statistical manual of mental disorders (4th edition, revised). Washington, D.C. (1994)
11. Stem JJ, Pascale L, Ackerman A: Life adjustment post myocardial infarction: Determining predictive variables. Arch'Intern Med 1977; 137:1680-1685
12. Travella JI, Forrester AW, Schultz SK, Robinson RG: Depression following myocardial infarction: A one year longitudinal study, hit J Psychiatry Med \994;24(suppl 4):357-369
13. Hance M, Camey RM, Freedland KE, Skala J: Depression in patients with coronary heart disease: A twelve-month follow-up. Gen Hasp Psychiatry, 1995;18:61-65
14. Wells KB, Bumam MA, Rogers W, Hays R, Camp P: The course of depression in adult outpatients. Results from the Medical Outcomes Study. Arch Gen Psychiatry 1992;49:788-794
15. Wells KB, Stewart A, Hays R, Bumam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J: The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. J Am Med Assoc 1989;262:914-919
16. Ormel J, VonKorff M, Ustun TB, Pini S, Korten A, Oldehinkel T: Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. J Am Med Assoc 1994;272:1741-1748
17. Lloyd GG, Cawley RH: Distress or illness? A study of psychosocial symptoms after myocardial infarction. Br J Psychiatry 1983; 142:120-125
18. Mayou R, Foster A, Williamson B: Psychosocial adjustment in patients one year after myocardial infarction. J Psychosom Res 1978; 22:447-453
19. Bryant B, Mayou R: Prediction of outcome after coronary artery surgery. J Psychosom Res 1989;33:419-427
20. Skala JA, Freedland KE, Camey RM: Depressive symptoms and functional status in patients with congestive heart failure. Ann Behavior Med 1995;17:S130
21. Carney RM, Rich MW, Tevelde A, Saini J, Clark K, Jaffe AS: Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627-633
22. Schleifer SJ, Macari MM, Slater W, Kahn M, Zucker H, Gorlin R: Predictors of outcome after myocardial infarction: Role of depression. Circulation 1974;2:2-10
23. Frasure-Smith N, Lespérance F, Talajic M: Depression following myocardial infarction. Impact on 6-month survival. J Am Med /Usocl993;270:1819-1825
24. Kennedy GJ, Hofer MA, Cohen D, Shindledecker MA, Fisher JD: Significance of depression and cognitive impairment in patients undergoing programmed stimulation of cardiac arrythmias. Psychosom Med 1987;49:410-421
25. Ahem DK, Gorkin L, Anderson JL, Tiemey C, Hallstrom A, Ewart C, Capone RJ, Schron E, Kornfeld D, Herd JA: Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990;66:59-62
26. Ladwig KH, Kieser M, Konig J, Breithardt G, Borggrefe M: Affective disorders and survival after myocardial infarction. Results from the postinfarction late potential study. Enr Heart J 1991;12:959-964
27. Esler M, Turbott J, Schwarz R, Leonard P, Bobik A, Skews H, Jackman G: The peripheral kinetics of norcpinephrine in depressive illness. Arch Gen Psychiatry-1982:39:295-300
28. Roy A, Pickar D, De Jong J, Karoum F, Linnoila M: Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Arch Gen Psychiatry 1988;45:849-857
29. Siever LJ, Davis KL: Overview: Toward a dysregulation hypothesis of depression. Am J Psychiatry 1985;142:1017-1031
30. Hjemdahl P, Larrson T, Wallen NH: Effects of stress and B-blockade on platelet function. Circulation 1991 ;84(suppl 4):44-61
31. Podrid PJ, Fuchs T, Candinas R: Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 1990; 82(suppl 1):103-110
32. Carney RM, Saunders RD, Freedland KB, Stein P, Rich MW, Jaffe AS: Depression is associated with reduced heart rate variability in patients with coronary heart disease. Am J Cardiol 1995;76: 562-564
33. Camey RM, Freedland KB, Rich MW, Smith LJ, Jaffe AS: Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med 1993;95:23-28
34. Kurosawa H, Shimizu Y, Nishimatsu Y, Hirose S, Takano T: The relationship between mental disorders and physical severities in patients with acute myocardial infarction." Jpn Circ Res 1983;47: 723-728
35. Rifkin A: Depression in physically ill patients. Don't dismiss it as understandable.Posgrad Merf 1992;92(suppl3):146-154
36. Freedland KE, Lustman PJ, Camey RM, Hong BA: Underdiagnosis of depression in patients with coronary artery disease: The role.of nonspecific symptoms. Int J Psychiatry Mcd 1992; 22:221-229
37. BeclrAT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961 ;4: 561-571
38. Spitzer RL, Williams JEW, Kroenke K: Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study.-MmA/erfAsttJC 1994;272:1749-1756
39. Pary RP, Tobias CR, Lippmann S: Antidepressants and the cardiac patient: Selecting an appropriate medication. PostgradMed 1989; 85(suppl l):267-269
40. Giardina EGV, Bigger JT Jr, Johnson LL: The effect of imipramine and nortriptyline on ventricular premature depolarizations and left I ventricular function. Circulation 1981 ;64(suppl 4):316
41. Classman AH, RooseSP: Delusional depression: A distinct clinical entity? Arch Gen Psychiatry 1981;38:424-427
42. Glassman AH, RooseSP, Giardina EGV: Cardiovascular effects of tricyclic antidepressants. In Psychophannacology: Tlie Tliird Generation of Progress (Ed. Meltzer HY), p. 1437-1442. New York: Raven Press, 1987
43. Glassman AH, Bigger JT Jr: Cardiovascular effects of therapeutic doses of tricyclic antidepressants: A review. Arch Gen Psychiatry 1981:38:815-820
44. Roose SP, Glassman AH, Giardina EGV, Johnson LL, Walsh T, Bigger JT Jr: Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. J Clin Psychophannacol 1987;7(suppl 4):247-251
45. Bigger JT Jr, Giardina EGV, Perel JM, Kantor SJ, Glassman AH: Cardiac antiarrhythmic effect of imipramine hydrochloride. N Engl J Med 1977;296:206-208
46. Finkel MS, Gaffney A, Laghrissi-Thode F, Pollock BG, Kennedy J, Nelson C, Gergel I, McCafferty JP, Roose SP: Randomized trial of antidepressants in patients with ischemie heart disease (abstr). J Am Coll Cardiol 1996;27(2a):186a
47. Glassman AH, Roose SP, Bigger JT Jr: The safety of tricyclic antidepressants in cardiac patients. Risk-benefit considered. J Am MedAssoc 1993:269:2673-2675
48. Nemeroff CB, De Vane CL, Pollock BG: Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153: 311-320
49. Ormel J, VonKorff M, vanden Brink W, Katon W, Brielman E, Oldehinkel T: Depression, anxiety and disability show synchrony of change. Am J Publ Health 1993;83:385-390
50. VonKorff M, Ormel J, Katon W, Lin EHB: Disability and depression among high utilizers of health care: A longitudinal analysis. Arch Gen Psychiatry 1992;49:91-100